survival

You have access
¹⁸F-FDG PET/CT to Predict Response to Neoadjuvant Chemotherapy and Prognosis in Inflammatory Breast Cancer
Laurence Champion, Florence Lerebours, Jean-Louis Alberini, Emmanuelle Fourme, Eric Gontier, Françoise Bertrand and Myriam Wartski

Journal of Nuclear Medicine September 1, 2015, 56 (9) 1315-1321; DOI: https://doi.org/10.2967/jnumed.115.158287
You have access
PET Response Criteria in Solid Tumors Predicts Progression-Free Survival and Time to Local or Distant Progression After Chemotherapy with Regional Hyperthermia for Soft-Tissue Sarcoma
Wolfgang P. Fendler, Mona Lehmann, Andrei Todica, Ken Herrmann, Thomas Knösel, Martin K. Angele, Hans Roland Dürr, Josefine Rauch, Peter Bartenstein, Clemens C. Cyran, Marcus Hacker and Lars H. Lindner

Journal of Nuclear Medicine April 1, 2015, 56 (4) 530-537; DOI: https://doi.org/10.2967/jnumed.114.152462
You have access
Somatostatin Receptor–Targeted Radiopeptide Therapy with ⁹⁰Y-DOTATOC and ¹⁷⁷Lu-DOTATOC in Progressive Meningioma: Long-Term Results of a Phase II Clinical Trial
Nicolas Marincek, Piotr Radojewski, Rebecca A. Dumont, Philippe Brunner, Jan Müller-Brand, Helmut R. Maecke, Matthias Briel and Martin A. Walter

Journal of Nuclear Medicine February 1, 2015, 56 (2) 171-176; DOI: https://doi.org/10.2967/jnumed.114.147256
You have access
Clinical Significance of Tryptophan Metabolism in the Nontumoral Hemisphere in Patients with Malignant Glioma
David O. Kamson, Tiffany J. Lee, Kaushik Varadarajan, Natasha L. Robinette, Otto Muzik, Pulak K. Chakraborty, Michael Snyder, Geoffrey R. Barger, Sandeep Mittal and Csaba Juhász

Journal of Nuclear Medicine October 1, 2014, 55 (10) 1605-1610; DOI: https://doi.org/10.2967/jnumed.114.141002
You have access
Follow-up or Surveillance ¹⁸F-FDG PET/CT and Survival Outcome in Lung Cancer Patients
Alexander J. Antoniou, Charles Marcus, Abdel K. Tahari, Richard L. Wahl and Rathan M. Subramaniam

Journal of Nuclear Medicine July 1, 2014, 55 (7) 1062-1068; DOI: https://doi.org/10.2967/jnumed.113.136770
You have access
Adjuvant Intraarterial Lipiodol or ¹³¹I-Lipiodol After Curative Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial
Jérôme Dumortier, Evelyne Decullier, Marie-Noëlle Hilleret, Sylvie Bin-Dorel, Pierre-Jean Valette, Olivier Boillot, Christian Partensky, Christian Letoublon, Christian Ducerf, Vincent Leroy, Jean-Philippe Vuillez and Françoise Borson-Chazot

Journal of Nuclear Medicine June 1, 2014, 55 (6) 877-883; DOI: https://doi.org/10.2967/jnumed.113.131367
You have access
Prognosis Related to Metastatic Burden Measured by ¹⁸F-Fluorocholine PET/CT in Castration-Resistant Prostate Cancer
Sandi A. Kwee, John Lim, Alex Watanabe, Kathleen Kromer-Baker and Marc N. Coel

Journal of Nuclear Medicine June 1, 2014, 55 (6) 905-910; DOI: https://doi.org/10.2967/jnumed.113.135194
You have access
Initial Metabolic Tumor Volume Measured by ¹⁸F-FDG PET/CT Can Predict the Outcome of Osteosarcoma of the Extremities
Byung Hyun Byun, Chang-Bae Kong, Jihyun Park, Youngseok Seo, Ilhan Lim, Chang Woon Choi, Wan Hyeong Cho, Dae-Geun Jeon, Jae-Soo Koh, Soo-Yong Lee and Sang Moo Lim

Journal of Nuclear Medicine October 1, 2013, 54 (10) 1725-1732; DOI: https://doi.org/10.2967/jnumed.112.117697
You have access
Baseline ¹⁸F-FDG PET/CT Parameters as Imaging Biomarkers of Overall Survival in Castrate-Resistant Metastatic Prostate Cancer
Hossein Jadvar, Bhushan Desai, Lingyun Ji, Peter S. Conti, Tanya B. Dorff, Susan G. Groshen, Jacek K. Pinski and David I. Quinn

Journal of Nuclear Medicine August 1, 2013, 54 (8) 1195-1201; DOI: https://doi.org/10.2967/jnumed.112.114116
You have access
Comparison of EORTC Criteria and PERCIST for PET/CT Response Evaluation of Patients with Metastatic Colorectal Cancer Treated with Irinotecan and Cetuximab
Kristin Skougaard, Dorte Nielsen, Benny Vittrup Jensen and Helle Westergren Hendel

Journal of Nuclear Medicine July 1, 2013, 54 (7) 1026-1031; DOI: https://doi.org/10.2967/jnumed.112.111757

Main menu

User menu

Search

survival

Pages